Motor neurone disorders (modified from Kato et al, 2003, with permission)
Genetically determined forms of motor neuron disorder |
Familial MND (ALS) (see table 1) |
Brown-Vialetto-Van Laere syndrome (early onset bulbar and spinal ALS with sensorineural deafness) |
Fazio-Londe syndrome (infantile progressive bulbar palsy) |
Hexosaminidase deficiency |
Hereditary spastic paraplegia (many forms, including ALS2, ALS4) |
Spinal muscular atrophy (SMA)
|
X linked bulbar and spinal muscular atrophy (Kennedy’s disease) Hereditary motor and sensory neuropathy (predominantly motor forms) |
Multisystem disorders with occasional anterior horn cell involvement (e.g. SCA3) |
Algrove syndrome |
Apparently sporadic (idiopathic) forms of motor neuron disorder Sporadic MND (progressive bulbar palsy; classical limb onset MND/ALS; progressive spinal muscular atrophy) |
Primary lateral sclerosis |
Distal sporadic focal spinal muscular atrophy (“Hirayama syndrome”) |
Atypical juvenile onset MND in South India (“Madras” form of MND) |
Western Pacific and other similar forms of MND/ALS (Guam, Kiipeninsula, New Guinea) |
Guadeloupe PSP-dementia-MND/ALS syndrome |
MND with frontotemporal dementia (MND-dementia syndrome; Pick’s disease with MND) |
Multiple system atrophy |
Progressive supranuclear palsy |
Corticobasal ganglionic degeneration |
Acquired forms of motor neuron disorder |
HTLV-1 associated myelopathy (HAM) |
HIV-associated MND syndrome |
Creutzfeld-Jacob disease (amyotrophic forms) |
Multifocal motor neuronopathy |
Acute poliomyelitis |
Lead, mercury toxicity |
Neurolathyrism (caused by Lathyrus sativa, containing b—oxalyl-L-aminoacid, BOAA) |
Konzo (due to toxic cyanogenic cassava) |
Radiation (e.g. cervical and lumbosacral radiculopathy) |
Post- polio progressive muscular atrophy syndrome |
Autoimmune disorders (e.g. Sjögren’s disease) |
Endocrinopathy (hyperthyroidism, hyperparathyroidism, hypoglycaemia) |